EP1472256 - Bibliographic data

PIPERIDINE DERIVATIVES

Last update 03/06/2025
Legal status Invention expirée
Origin Euro-PCT

(73) Holder

NERRE THERAPEUTICS LIMITED

Stevenage Bioscience Catalyst, Office F25 Incubator Building, Gunnels Wood Road
SG1 2FX
s
STEVENAGE HERTS
Royaume-Uni
(72) Inventors

ALVARO, Giuseppe GlaxoSmithKline SpA

Via Alessandro Fleming 2
I-37135 Verona
Italie

DI FABIO, Romano GlaxoSmithKline SpA

Via Alessandro Fleming 2
I-37135 Verona
Italie

TRANQUILLINI, Maria Elvira GlaxoSmithKline SpA

Vi a Alessandro Fleming 2
I-37135 Verona
Italie

SPADA, Simone GlaxoSmithKline SpA

Via Alessandro Fleming 2
I-37135 Verona
Italie
(74) Agent

Mail recipient

Cabinet

MURGITROYD

165-169 Scotland Street
G5 8PL
GLASGOW
Royaume-Uni

(21) Request number EP03702621.8
(22) Request date 10/02/2003

(11) Publication number EP1472256
Publication date 02/11/2005

(54) Title of the invention PIPERIDINE DERIVATIVES
(51) International classification None
International classification (before reform)

Claimed priority

(31) Number: 0203020
(32) Date: 08/02/2002
(33) Country: GB

Initial application None
Divisional application EP05077500.6 /EP1666465 None

Expected annuity None
Last annuity Annuity: 20 - Payment date 04/02/2022

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2005/4, of 31/12/2005

CESSION - bulletin 2013/3, of 30/09/2013

History

Publication de la délivrance du brevet européen - Legal date 02/11/2005


Constitution de mandataire pour un dossier - Legal date 09/08/2013


Expiration de l'invention - Legal date 11/02/2023